Raily Aesthetic Medicine International Holdings Limited (HK:2135) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Raily Aesthetic Medicine International Holdings Limited announced the disposal of its subsidiary, Jiumei Xinhe, resulting in an estimated net loss of RMB740.55. The proceeds from this transaction will be utilized as general working capital for the company. This move reflects the company’s strategic adjustments amidst challenging financial conditions.
For further insights into HK:2135 stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Netflix Wins Shareholder Lawsuit Alleging Misleading Growth Forecasts
- OpenAI’s Text-Video Generator Sora Leaked by Artists in Protest
- Palantir Gets New Street-High Price Target from Analysts on Nasdaq Shift
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
